AzurRx BioPharma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
429.90
733.60
734.50
754.00
798.40
Gross Income
429.90
733.60
734.50
754.00
798.40
SG&A Expense
1,899.20
3,995.20
5,890.70
9,327.20
11,994.60
EBIT
2,329.10
4,728.80
6,625.20
10,081.20
12,793
Unusual Expense
1.40
386.10
2,029.00
140.00
638.70
Non Operating Income/Expense
30.70
-
-
-
-
Interest Expense
68.10
1,587.50
5,937.50
875.20
101.80
Pretax Income
2,365.10
5,930.20
14,591.70
11,096.40
13,533.60
Consolidated Net Income
2,365.10
5,930.20
14,591.70
11,096.40
13,533.60
Net Income
2,365.10
5,930.20
14,591.70
11,096.40
13,533.60
Net Income After Extraordinaries
2,365.10
5,930.20
14,591.70
11,096.40
13,533.60
Net Income Available to Common
2,365.10
5,930.20
14,591.70
11,096.40
13,533.60
EPS (Basic)
0.24
0.61
2.24
1.04
0.88
Basic Shares Outstanding
9,775.10
9,775.10
6,504.80
10,628.80
15,439.30
EPS (Diluted)
0.24
0.61
2.24
1.04
0.88
Diluted Shares Outstanding
9,775.10
9,775.10
6,504.80
10,628.80
15,439.30
EBITDA
1,899.20
3,995.20
5,890.70
9,327.20
11,994.60
About AzurRx BioPharma
View Profile
